Amedeo Smart

Free Medical Literature Service


 

Amedeo

Arrhythmias

  Free Subscription

Articles published in
Br J Pharmacol
    June 2024
  1. NISKALA A, Heijman J, Dobrev D, Jespersen T, et al
    Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation.
    Br J Pharmacol. 2024 Jun 15. doi: 10.1111/bph.16470.
    >> Share

    April 2024
  2. LEI CL, Whittaker DG, Mirams GR
    The impact of uncertainty in hERG binding mechanism on in silico predictions of drug-induced proarrhythmic risk.
    Br J Pharmacol. 2024;181:987-1004.
    >> Share

    February 2024
  3. CHEN IS, Yasuda J, Notomi T, Nakamura TY, et al
    Licorice metabolite 18beta-glycyrrhetinic acid activates G protein-gated inwardly rectifying K(+) channels.
    Br J Pharmacol. 2024;181:447-463.
    >> Share

    December 2022
  4. SAADEH K, Nantha Kumar N, Fazmin IT, Edling CE, et al
    Anti-malarial drugs: Mechanisms underlying their proarrhythmic effects.
    Br J Pharmacol. 2022;179:5237-5258.
    >> Share

    October 2022
  5. CLARK AP, Wei S, Kalola D, Krogh-Madsen T, et al
    An in silico-in vitro pipeline for drug cardiotoxicity screening identifies ionic pro-arrhythmia mechanisms.
    Br J Pharmacol. 2022;179:4829-4843.
    >> Share

    July 2022
  6. KOHAJDA Z, Virag L, Hornyik T, Husti Z, et al
    In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
    Br J Pharmacol. 2022;179:3382-3402.
    >> Share

    June 2022
  7. CHAMPEROUX P, Fares R, Bastogne T, Richard S, et al
    Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
    Br J Pharmacol. 2022 Jun 24. doi: 10.1111/bph.15905.
    >> Share

  8. BANNISTER ML, MacLeod KT, George CH
    Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.
    Br J Pharmacol. 2022;179:2558-2563.
    >> Share

    May 2022
  9. HESKETH LM, Sikkel MB, Mahoney-Sanchez L, Mazzacuva F, et al
    OCT2013, an ischaemia-activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine.
    Br J Pharmacol. 2022;179:2037-2053.
    >> Share

    March 2022
  10. HORNYIK T, Rieder M, Castiglione A, Major P, et al
    Transgenic rabbit models for cardiac disease research.
    Br J Pharmacol. 2022;179:938-957.
    >> Share

  11. LOEN V, Vos MA, van der Heyden MAG
    The canine chronic atrioventricular block model in cardiovascular preclinical drug research.
    Br J Pharmacol. 2022;179:859-881.
    >> Share

    December 2021
  12. ROBINSON VM, Alsalahat I, Freeman S, Antzelevitch C, et al
    A Carvedilol Analogue, VK-II-86, Prevents Hypokalaemia-induced Ventricular Arrhythmia through Novel multi-Channel Effects.
    Br J Pharmacol. 2021 Dec 7. doi: 10.1111/bph.15775.
    >> Share

    November 2021
  13. SANDER P, Feng M, Schweitzer MK, Wilting F, et al
    Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca(2+) uptake and suppress cardiac arrhythmogenesis.
    Br J Pharmacol. 2021;178:4518-4532.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016